Incyte (INCY)Officer filed to sell ~$2.8M

~$2.8M

planned to sell · 23K shares, around Sep 15, 2026

Planned for

Sep 15, 2026

Notice filed

Sep 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 16, 2026Insider · 2 peopleInsiders: 2 sales (~$341K)
2. Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
3. Jul 31, 2026Insider · 2 peopleInsiders: 12 sales (~$6.9M)
4. Aug 3, 2026InsiderOfficer sold ~$729K of INCY shares in the open market
5. Aug 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
6. Aug 12, 2026InsiderOfficer sold ~$1.3M of INCY shares in the open market
7. Aug 19, 2026InsiderOfficer sold ~$1.36M of INCY shares in the open market
8. Sep 15, 2026Insider · 1 personInsiders: 2 sales (~$2.8M)

What came next

1. Sep 25, 2026FDAFDA drug approval: Atebrioz

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Incyte

For Incyte, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 14 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INCY page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Incyte

• SEC Form 4Sep 17, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Aug 20, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its INCY page.